Status:
UNKNOWN
Impact of Breathing Route on CPAP Effectiveness to Treat Obstructive Sleep Apnea
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
OSA
Apnea+Hypopnea
Eligibility:
All Genders
18-85 years
Brief Summary
To determine the impact of the CPAP route (oronasal vs oral) in patients diagnosed with moderate-severe OSA using CPAP with oronasal mask on CPAP level, residual AHI, and peak flow. In addition, the i...
Detailed Description
Application of Continuous Positive Upper Airway Pressure (CPAP) during sleep using nasal mask is the gold standard treatment for Obstructive Sleep Apnea (OSA). In clinical practice, many patients with...
Eligibility Criteria
Inclusion
- Diagnosis of moderate or severe OSA in treatment with CPAP in an oronasal mask
- 18 Years to 85 Years (Adult, Older Adult) (Adult, Older Adult)
Exclusion
- Other sleep disturbance (insomnia, parasomnias, narcolepsy, central sleep apnea).
- Uncontrolled clinical disease (diabetes, kidney or heart failure, recent stroke or coronary failure and recent postoperative period, oxygen dependent COPD).
- Patients adapted to other types of masks.
Key Trial Info
Start Date :
January 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 18 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05272761
Start Date
January 10 2021
End Date
February 18 2024
Last Update
May 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundação Zerbini - Instituto do Coração (InCor)
São Paulo, São Paulo, Brazil, 054039000